Black Rock Inc. Terns Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,315,529 shares of TERN stock, worth $19.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,315,529

Previous 3,408,978 2.74%

Holding current value

$19.9 Million

Previous $22.1 Million 1.69%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.86 - $8.19 $454,162 - $765,347	-93,449 Reduced 2.74%	3,315,529 $21.7 Million
Q4 2023 Feb 13, 2024	BUY	$3.37 - $6.86 $822,829 - $1.67 Million	244,163 Added 7.71%	3,408,978 $22.1 Million
Q3 2023 Nov 13, 2023	BUY	$4.7 - $8.55 $123,544 - $224,745	26,286 Added 0.84%	3,164,815 $15.9 Million
Q2 2023 Aug 11, 2023	BUY	$7.35 - $13.29 $17.9 Million - $32.4 Million	2,437,862 Added 347.93%	3,138,529 $27.5 Million
Q1 2023 May 12, 2023	BUY	$7.91 - $12.0 $3.17 Million - $4.81 Million	401,229 Added 133.99%	700,667 $8.3 Million

Q4 2022 Feb 13, 2023	BUY	$4.62 - $10.18 $60,729 - $133,816	13,145 Added 4.59%	299,438 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$1.87 - $6.42 $255,750 - $878,031	136,765 Added 91.46%	286,293 $1.69 Million
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.0 $881,119 - $1.76 Million	-587,413 Reduced 79.71%	149,528 $371,000
Q1 2022 May 12, 2022	SELL	$2.83 - $6.7 $24,321 - $57,579	-8,594 Reduced 1.15%	736,941 $2.19 Million
Q4 2021 Feb 10, 2022	BUY	$5.65 - $10.73 $807,831 - $1.53 Million	142,979 Added 23.73%	745,535 $5.27 Million
Q3 2021 Nov 09, 2021	BUY	$7.22 - $13.46 $1.19 Million - $2.22 Million	164,952 Added 37.69%	602,556 $6.28 Million
Q2 2021 Aug 11, 2021	BUY	$12.26 - $22.0 $5.37 Million - $9.63 Million	437,604 New	437,604 $5.37 Million

Others Institutions Holding TERN

# of Institutions

118

Shares Held

61M

Call Options Held

155K

Put Options Held

48.3K

View Full List

About Terns Pharmaceuticals, Inc.

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $226M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

More about TERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account